FDA to create and staff inspection offices in China, India

The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries, as a means to step up its regulatory enforcement of the growing inventory of drug products being made abroad, commissioner Andrew von Eschenbach told a House Energy and Commerce subcommittee hearing.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions